SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000850261-18-000044
Filing Date
2018-11-27
Accepted
2018-11-27 19:48:19
Documents
1
Period of Report
2018-11-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_154336608310581.html 4  
1 FORM 4 wf-form4_154336608310581.xml 4 3984
  Complete submission text file 0000850261-18-000044.txt   5450
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O PROTINE DESIGN LAB 37481 MARSTEN DR NEWARK CA 94560
Business Address
SHAH JAISIM (Reporting) CIK: 0001242133 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36150 | Film No.: 181203986